Lustgarten Foundation: Correlative Studies Awards Program (CSAP) in Pancreatic Cancer - LOI

The Lustgarten Foundation has entered into a formal partnership with NCI’s Cancer Therapy Evaluation Program (CTEP). CTEP is the world’s largest publicly funded oncology clinical trials organization, which focuses on early phase trials that might not otherwise be supported. As part of the new partnership, The Lustgarten Foundation will fund selected correlative research applications directly linked to a CTEP-sponsored clinical trial of novel therapeutics for pancreatic cancer. LF will review only LOIs for Correlative Funding for studies which are also being considered for clinical trial support by CTEP and which are specific to Pancreatic Adenocarcinoma.
http://www.lustgarten.org/page.aspx?pid=666